Bridgepoint Development Capital Recapitalizes Prescient Healthcare Group

Align Capital Partners Recapitalizes Premier Biotech

December 7, 2022

Medical Devices

Align Capital Partners has completed a recapitalization of Premier Biotech, a Minneapolis-based provider of point-of-care drugs of abuse testing devices and accredited laboratory services. Cascadia Capital served as exclusive financial advisor; Align will partner with management to scale the business, accelerate product development and expand the company's reach across workplace, government and clinical end markets.

Prescient Acquires Strategic North

March 2, 2022

Consulting

Prescient, a PE-backed biopharma product and portfolio strategy consultancy, has acquired Strategic North, a UK-based commercial strategy and brand research consultancy serving pharmaceutical and biotech clients. The acquisition is an add-on to Prescient’s platform intended to deepen its commercial and brand strategy capabilities for global pharma and biotech customers.

Charlesbank Capital Partners Makes Growth Investment in Bridgepointe Technologies

January 11, 2022

IT Services

Charlesbank Capital Partners has made a strategic growth investment in Bridgepointe Technologies, a San Mateo-based IT strategy and advisory firm. Bridgepointe raised more than $100 million in total proceeds to fund partner recruitment and enablement, service and brand expansion, key hires, and future acquisitions.

Brentwood Associates Recapitalizes MedBridge

January 13, 2021

Healthcare Services

Brentwood Associates has recapitalized MedBridge, a SaaS provider of patient engagement and clinical education solutions, with LLR Partners and senior management retaining significant minority stakes. The investment will fund continued organic growth, support future acquisitions, and enable expansion into additional healthcare specialties and care settings.

Prescient Healthcare Group Acquires Uptake

January 9, 2026

Healthcare Services

Prescient Healthcare Group has acquired Uptake (Uptake Strategies Ltd), a global healthcare consultancy, to strengthen Prescient’s commercial practice and expand capabilities for pharmaceutical and biotech clients. The deal is supported by Prescient’s existing investor Bridgepoint Development Capital; Uptake’s CEO Stephanie Hall will join Prescient’s board and lead the combined Commercial Practice during integration.

424 Capital Acquires Majority Stake in Health Perspectives Group

September 30, 2021

Healthcare Services

424 Capital closed a majority investment in Health Perspectives Group (HPG) in early August 2021 to support HPG’s growth and expansion of its patient engagement offerings. The deal was completed alongside longtime 424 partners Eagle Private Capital, Plexus Capital and Enterprise Bank and will fund expansion of HPG’s tech-enabled patient engagement and clinical trial support services for pharmaceutical and biotechnology clients.